Clinical trial in Uganda will test alternative diagnostic tool and oral chemotherapy, study genetic differences
Aug. 15, 2017
| By Mary Engel / Fred Hutch News Service
Researchers from Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute are launching a clinical study in the Ugandan capital Kampala that could change the way breast cancer in sub-Saharan Africa is diagnosed and treated.
New research writes latest chapter in one drug's story
June 27, 2017
| by Susan Keown / Fred Hutch News Service
The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.